These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 34634770)
1. Real World Analysis of Response Rate and Efficacy of Oral Ketoconazole in Patients with Recalcitrant Tinea Corporis and Cruris. Arora P; Sardana K; Kulhari A; Kaur R; Rawat D; Panesar S Am J Trop Med Hyg; 2021 Oct; 106(1):38-44. PubMed ID: 34634770 [TBL] [Abstract][Full Text] [Related]
2. Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation. Sardana K; Gupta A; Sadhasivam S; Gautam RK; Khurana A; Saini S; Gupta S; Ghosh S Antimicrob Agents Chemother; 2021 Jul; 65(8):e0032121. PubMed ID: 34097482 [TBL] [Abstract][Full Text] [Related]
4. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study. Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163 [TBL] [Abstract][Full Text] [Related]
5. New Antifungal Agents and New Formulations Against Dermatophytes. Gupta AK; Foley KA; Versteeg SG Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503 [TBL] [Abstract][Full Text] [Related]
6. An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Sardana K; Sharath S; Khurana A; Ghosh S Expert Rev Anti Infect Ther; 2023; 21(9):977-991. PubMed ID: 37606343 [TBL] [Abstract][Full Text] [Related]
7. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. Shi JP; Zhang H; Zhang ZD; Zhang GH; Gao AL; Xiang SB Chin J Integr Med; 2011 Jul; 17(7):499-504. PubMed ID: 21725874 [TBL] [Abstract][Full Text] [Related]
9. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India). Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646 [TBL] [Abstract][Full Text] [Related]
10. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile. Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507 [TBL] [Abstract][Full Text] [Related]
11. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. Bonifaz A; Saúl A Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of a terbinafine-resistant trichophyton mentagrophytes type VIII]. Gawaz A; Nenoff P; Uhrlaß S; Schaller M Hautarzt; 2021 Oct; 72(10):900-904. PubMed ID: 34241651 [TBL] [Abstract][Full Text] [Related]
13. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre? Sardana K; Kaur R; Arora P; Goyal R; Ghunawat S Indian Dermatol Online J; 2018; 9(2):90-95. PubMed ID: 29644192 [TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore. Goh CL; Tay YK; Ali KB; Koh MT; Seow CS Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147 [TBL] [Abstract][Full Text] [Related]
15. Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy. Gaurav V; Bhattacharya SN; Sharma N; Datt S; Kumar P; Rai G; Singh PK; Taneja B; Das S J Mycol Med; 2021 Mar; 31(1):101087. PubMed ID: 33360137 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes. Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J; Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330 [TBL] [Abstract][Full Text] [Related]
19. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. Singh S; Chandra U; Anchan VN; Verma P; Tilak R Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466 [TBL] [Abstract][Full Text] [Related]
20. Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale. Kakurai M; Harada K; Maeda T; Hiruma J; Kano R; Demitsu T J Dermatol; 2020 Apr; 47(4):e104-e105. PubMed ID: 31994232 [No Abstract] [Full Text] [Related] [Next] [New Search]